R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2022
Back to search
Official data from USPTO
ENBIFELIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/15/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
01/11/2019
Registration date
03/15/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2022
Last transaction
03/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Incheon, KR
Examiner
WATSON, BRIDGET
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Samsung Bioepis Co., Ltd.
Representatives
STEPHEN R. BARRESE, ESQ. DILWORTH & BARRESE, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for medical usepharmaceutical preparations for immunoregulationfor treatment of autoimmune diseasesfor use as anti-cancer agentsfor treatment of cancerfor treatment of tumorsfor treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
Publications
History of USPTO decisions and trademark events.
25 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/28/2021
PUBO
PUBLISHED FOR OPPOSITION
12/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/22/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/25/2021
DOCK
ASSIGNED TO EXAMINER
10/15/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/13/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/25/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/08/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/15/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/14/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/11/2019
GNSL
LETTER OF SUSPENSION E-MAILED
07/11/2019
CNSL
SUSPENSION LETTER WRITTEN
07/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2019
ALIE
ASSIGNED TO LIE
07/06/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/01/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/28/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/28/2019
CNSL
SUSPENSION LETTER WRITTEN
03/28/2019
DOCK
ASSIGNED TO EXAMINER
03/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/02/2019
NWAP
NEW APPLICATION ENTERED
01/15/2019
Continuous trademark protection
Get notified about every new filing that threatens ENBIFELIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.